about
Human Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data.Cervical cancer: Can it be prevented?The etiologic role of human papillomavirus in penile cancers: a study in Vietnam.Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer.miR-34a and miR-125b Expression in HPV Infection and Cervical Cancer Development.CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical CancerFiber-bundle microendoscopy with sub-diffuse reflectance spectroscopy and intensity mapping for multimodal optical biopsy of stratified epithelium.A review of methods for detect human Papillomavirus infectionRare subtype(s) and frequency of multi-viral subtype high-risk human papilloma virus infection in high-grade squamous intraepithelial lesion and squamous cell carcinoma in a cervical carcinoma prevalent developing country: a multiplex real-time polyMicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a.Targeting CDKN3 in cervical cancer.Regulation of p14ARF expression by HPV-18 E6 variants.Let-7c is a Candidate Biomarker for Cervical Intraepithelial Lesions: A Pilot Study.Characterization of human papillomavirus genotypes and HPV-16 physical status in cervical neoplasias of women from northern Portugal.S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results.Characterization of JAK2 V617F (1849 G > T) Mutation in Cervical Cancer Related to Human Papillomavirus and Sexually Transmitted Infections.
P2860
Q31012345-018411CD-B9D2-4705-90A1-92A324BEA037Q34031277-F01A16F0-7BB8-4A00-8EEC-04B117FC646DQ34321558-CCC423F4-5702-404A-A88A-0E08FE032BA7Q34584632-3E4183AB-1F17-43FA-B0BB-35A0EE8CB386Q35769117-57BCB174-3D8D-422A-935D-14929F428481Q35776083-41649B58-78E5-4D0A-AB7A-DE91E61E46DFQ35880342-F4903837-751F-4CBA-BC36-C3280A0B8F2BQ36427451-270DD0F0-4EAE-4C53-BBC4-AC2E164BEF43Q37278764-4F156210-736A-4718-B801-87D89E98A73AQ38176833-9A7079A9-119E-48A2-AE62-CC99445ED237Q38242742-CA7BCB1B-393C-4784-A74E-96EBF3E4BEBFQ39114874-7AF2309B-C78F-4D20-A8F7-EDF5BA4BE659Q40847638-8C7F5C29-8628-4D14-A382-3F4D10406B40Q42237918-14D73367-DCA6-429C-A813-E195DDD24151Q43972741-FF49AF60-B6B5-4D3A-A46A-30C59108AF9AQ53291378-ED007839-4D9E-4EFA-978E-79CA189AD856Q55060965-56ABCE09-C3D8-4C6F-A9E0-4D0EA576FE3EQ55711886-6E304F61-69B8-4B23-85EF-0665A78AE8AA
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biomarkers of cervical dysplasia and carcinoma
@ast
Biomarkers of cervical dysplasia and carcinoma
@en
type
label
Biomarkers of cervical dysplasia and carcinoma
@ast
Biomarkers of cervical dysplasia and carcinoma
@en
prefLabel
Biomarkers of cervical dysplasia and carcinoma
@ast
Biomarkers of cervical dysplasia and carcinoma
@en
P2860
P356
P1433
P1476
Biomarkers of cervical dysplasia and carcinoma
@en
P2093
Kenneth R Shroyer
Sonya J Hwang
P2860
P304
P356
10.1155/2012/507286
P577
2011-10-29T00:00:00Z